This post contains the thoughts of a shareholder who went

New Post Public Reply Private Reply Replies (1) Message Board
sevenOdouble
This post contains the thoughts of a shareholder who went to the yearly AGM & also went to the Lab tour. (bold is already accomplished since AGM in June.)

"Here is my perspective on what I heard thru discussions, the open meeting and the lab tour.

  • We can look forward to total redesign of the web page in the next few weeks.
  • No new valuation will be done as its deemed to time consuming and the cost/benefit at this point is not good. POET will engage the company that did the original document when required – meaning if and when an offer is being reviewed. It is believed that the valuation is certainly higher now than noted in the original valuation a couple years ago.
  • Burn rate has been reduced dramatically and was emphasized that everyone drove to the AGM and expenses monitored closely
  • Reiterated that they do not expect to need more capital before completion of sale or licensing
  • They are not happy either with current share price. Don’t appear to be happy on the TSX.V.
  • IBK continues to be confident
  • Good feedback in industry about Dr. C joining Board – some very surprised as he was retiring but wanted in on POET
  • It was stressed often that there is much they cannot say in public at this point and they will divulge pertinent info as soon as possible. No surprise here other than the fact it was stressed by management at several different times over the day
  • team is coming together to comprise the SSC and they are excited about it. I would guess they have had an offer but it was so low it was insignificant. They believe the technology is saleable now in its current development stage but will reap much more very shortly.
  • Meetings/discussions are ongoing with major players. There will not be one “white paper” per say, but they will adapt each confidential paper to the needs of the possible purchaser/licensee.
  • Decision made not to leave wafers with potential buyers. Concern IP will be jeopardized so POET engineer will demo wafers and oversee application at prospect’s site
  • They are pleased with Atomic relationship thus far. Has opened many doors and made good contacts possible, but seeing the decision makers is longer process, and maybe larger task, than they anticipated. They expect to ramp up contacts now with name change and lab back online.
  • Interviews have been done with some major US and Cdn media. Editors of those pubs in control of when articles will run, if at all.
  • Sandy caused power outage of main and back-up sources. Caused major problem and delay as previously noted. Explained very well. (another post here noted some more detail)
  • milestones still in place with timetables – they (including those at the lab) are very confident they will reach each milestone
  • techies who ares vested are wishing they had bought more shares and are believing/ hoping for public announcements on POET progress in the very near future.

So overall, a very positive experience. Management team, despite their positive spin on everything, did temper their enthusiasm somewhat and seemed very realistic about the future SP, making no rash predictions, but definitely unhappy with where we sit. They do believe their reputations are on the line with this technology and want it to succeed. The lab team is fantastic. It was like visiting the set of Big Bang. They are committed. POET is their lifeblood after years of invested time. They said several times that, at this point, they can see no reason why they cannot bring POET to the place where it will be fruitful for all involved and are excited it is so close. They are already looking towards the next phases of POET (quantum dots and more).

In summary. I would expect the announcement of the next milestone to be made shortly – this month as stated in the timetable. I would expect, given comments at the lab, milestone 6 to be ahead of schedule. I would expect to see more trading activity shortly as the “dog and pony” show gets underway. As one of the management team told us, if this (sale & or licensing) hasn't happened with a year, then he & others should be fired. Based on what I have seen and heard, sounds good to me."

POET Technologies Inc. (POET) Stock Research Links

POET Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Waters Acquires MOBILion: Ion Mobility Meets AI

Updated Category News Views 59

MOBILion Joins Waters' Fold: A New Era for Proteomics Ah, the biotech world just saw another big whirl with Waters Corporation snagging MOBILion Systems. Now, this isn't just some stroll in the market park. We're talking about weaving MOBILion's fancy high-resolution ion mobility separation tech right into Waters' already robust mass spectrometry setup. These folks are...

Continue Reading
Montefiore Einstein Takes On Breast Cancer's Hidden Battle

Updated Category News Views 11

Call me old-fashioned, but when cancer whispers in the shadows even after it's supposedly signed off the death certificate, you're dealing with one heck of a slippery adversary. That's where Montefiore Einstein Comprehensive Cancer Center comes in, armed with ten million greenbacks from the National Cancer Institute, primed to rattle the labyrinth of breast cancer...

Continue Reading
JLL Snaps Up Prime Boston Warehouse for $36M

Updated Category News Views 58

Diving Deep into JLL's Latest Acquisition If you blinked, you might have missed JLL Income Property Trust's latest power move. These folks just laid down $36 million for a prime 54,000-square-foot Class A distribution hub in Northborough, Massachusetts. This isn't just any run-of-the-mill facility; it's 100% leased to a heavy-hitting tenant for the next 14 years with neat...

Continue Reading
Sunrate's Bold Move: New Payment Bond with Netstorming

Updated Category News Views 18

Sunrate Joins Forces with Netstorming When two industry powerhouses shake hands, it's wise to sit up and listen. Sunrate, the global whiz in payment solutions, has linked arms with Netstorming, a tech-savvy pioneer in the travel sector. This ironclad partnership was announced at World Travel Market London 2026. Owners of travel businesses should take note: things are...

Continue Reading
MemorialCare Expands Cutting-Edge GERD Treatment Options

Updated Category News Views 182

Shifting the GERD Treatment Paradigm While everyone's talking about breakthrough technologies like AI and blockchain in medicine, MemorialCare seems to have quietly flipped the script on treating gastroesophageal reflux disease (GERD). They're sidestepping conventional maneuvers by embracing two procedures known as transoral incisionless fundoplication (TIF) and its...

Continue Reading
Mill Creek's Bold Move into Denver's Cherry Creek

Updated Category News Views 13

Taking a Stroll Down Cherry Creek The move by Mill Creek Residential into Cherry Creek North is a bold one, but they aren't exactly newcomers to this high-end neighborhood. They're planting their flag with the Modera Second Avenue, targeting Denver's upscale renters. With a Walk Score of 89, the location is a sweet spot for deep-pocketed folks who want the boutiques and...

Continue Reading
Midterms Stir Markets; Event Contracts Fuel Q3 Gains

Updated Category News Views 62

Midterms Mingle with Financial Markets Folks, throw those ballots into the ring, because today the midterms are kicking things off and boy, are they shaking up the game on these prediction markets. Traders and exchanges are on their toes, and the money's flowing like cold brew in July. Robinhood, Intercontinental Exchange, CME Group, and others reported noticeable ripples...

Continue Reading
Vanessa Hering's Empathetic Model Wins 2026 Herizon Award

Updated Category News Views 44

Recognizing a Game-Changer in Financial Wellness Vanessa Hering's name isn't just getting thrown around for no reason, folks. She's the client success officer at Beyond Finance, a heavyweight in the financial wellness arena, and she's just snagged the 2026 Herizon Award. This ain't some run-of-the-mill accolade; it acknowledges the profound changes she's spearheaded in...

Continue Reading
Jeep Wrangler Scrambler SRT: A Bold Off-Road Rebirth

Updated Category News Views 43

A New Legend in the Making Who would've thought we'd see the day when an SRT badge graced a Jeep Wrangler with such audacity? This ain't your typical Wrangler—they’ve slapped a bit of that CJ-8 throwback swagger, and given it the full-on SRT treatment. It's a mad machine, barreling into the future with one foot firmly planted in its legendary past. You ask any...

Continue Reading
Ravi Bhalla Snags Top Franchise Award with $5M Milestone

Updated Category News Views 7

From Local Fixture to National Recognition Ravi Bhalla, owner of PostalAnnex #16006 in Calabasas, CA, takes home the Crystal Award at Annex Brands' 2026 National Convention in Vegas. And let me tell you, this isn't just some shiny trophy to stuff in a display case. This is major. Shattering Sales Goals What's the big kerfuffle over? It's this: Bhalla cracked the $5...

Continue Reading

Top 5 Most Recently Viewed Articles

Dry Age-Related Macular Degeneration Market Growth Insights

Updated Category News Views 54

The Expansion of the Dry Age-Related Macular Degeneration Market The Dry Age-related Macular Degeneration (AMD) market is experiencing significant growth, with projections indicating an increase from USD 4.83 billion in recent years to an impressive USD 10.57 billion by the year 2032. This remarkable growth, anticipated at a compound annual growth rate (CAGR) of 9.1% from...

Continue Reading
Eli Lilly's Earnings Outlook: Focus on Game-Changing Drugs

Updated Category News Views 157

Eli Lilly's Earnings Outlook: A Critical Moment Eli Lilly & Co. (NYSE: LLY) is gearing up for its upcoming earnings report, an event that many investors will monitor closely. The pharmaceutical giant has recently solidified its dominance in the weight-loss drug sector with its newest offering, Zepbound, which currently holds an impressive 59% share of U.S. prescriptions....

Continue Reading
Dream Finders Homes Reports Strong Growth With New Acquisitions

Updated Category News Views 197

Dream Finders Homes' Third Quarter Performance Overview Dream Finders Homes, Inc. (NYSE: DFH) released its financial outcomes for the third quarter. The homebuilder showcased remarkable growth, with revenues reaching $986 million, up 10% compared to $894 million in the same quarter last year. Key Highlights from the Third Quarter 2024 Notable achievements include a 5%...

Continue Reading
CrowdStrike's SIEM Innovation Recognized in 2024 IDC MarketScape

Updated Category News Views 97

CrowdStrike's Recognition in the IDC MarketScape 2024 CrowdStrike (NASDAQ: CRWD) has achieved significant recognition for its contributions in the realm of cybersecurity, being named a Major Player in the IDC MarketScape's 2024 Worldwide Security Information and Event Management (SIEM) for Enterprise Vendor Assessment report. This assessment acknowledges CrowdStrike's...

Continue Reading
Innovative Therapeutic Chair Aimed at Enhancing Comfort

Updated Category News Views 305

Revolutionary Therapeutic Chair for Enhanced Comfort A new therapeutic chair has been developed to provide relief for those suffering from lower back pressure and pain. An inventor from Grayson identified the need for a chair that not only supports proper posture but also offers lumbar support, enhancing overall sitting experience. Features of the EVENT COMFORT CHAIR This...

Continue Reading